Case Reports
doi: 10.1016/s0140-6736(99)01178-2.
In-vivo demonstration of dopaminergic degeneration in dementia with Lewy bodies
- PMID: 10466669
- DOI: 10.1016/s0140-6736(99)01178-2
Item in Clipboard
Case Reports
In-vivo demonstration of dopaminergic degeneration in dementia with Lewy bodies
Lancet.
.
Abstract
With the dopaminergic presynaptic ligand FP-CIT and single photon emission tomography we have shown a severe dopaminergic degeneration in a patient with a necropsy confirmed diagnosis of dementia with Lewy bodies (DLB). We suggest that functional imaging of the nigrostriatal dopamine pathway helps to distinguish DLB from Alzheimer's disease during life.
Similar articles
-
Dementia with Lewy bodies: a comparison of clinical diagnosis, FP-CIT single photon emission computed tomography imaging and autopsy.J Neurol Neurosurg Psychiatry. 2007 Nov;78(11):1176-81. doi: 10.1136/jnnp.2006.110122. Epub 2007 Mar 12. J Neurol Neurosurg Psychiatry. 2007. PMID: 17353255 Free PMC article.
-
[DaT-SCAN SPECT in the differential diagnosis of dementia with Lewy bodies and Alzheimer's disease].Rev Neurol. 2005 Sep 1-15;41(5):276-9. Rev Neurol. 2005. PMID: 16138284 Spanish.
-
Dementia with lewy bodies: a study of post-synaptic dopaminergic receptors with iodine-123 iodobenzamide single-photon emission tomography.Eur J Nucl Med. 1997 Jun;24(6):609-14. doi: 10.1007/BF00841397. Eur J Nucl Med. 1997. PMID: 9169566
-
Imaging in Dementia With Lewy Bodies: An Overview.J Geriatr Psychiatry Neurol. 2016 Sep;29(5):254-60. doi: 10.1177/0891988716654984. J Geriatr Psychiatry Neurol. 2016. PMID: 27502300 Review.
-
Imaging of the dopaminergic system in differential diagnosis of dementia.Eur J Nucl Med Mol Imaging. 2008 Mar;35 Suppl 1:S51-7. doi: 10.1007/s00259-007-0702-0. Eur J Nucl Med Mol Imaging. 2008. PMID: 18214473 Review.
Cited by
-
The role of I-ioflupane SPECT dopamine transporter imaging in the diagnosis and treatment of patients with dementia with Lewy bodies.Neuropsychiatr Dis Treat. 2007 Jun;3(3):287-92. Neuropsychiatr Dis Treat. 2007. PMID: 19300562 Free PMC article.
-
Assessment of diffuse Lewy body disease by 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG PET).BMC Nucl Med. 2003 Feb 20;3(1):1. doi: 10.1186/1471-2385-3-1. BMC Nucl Med. 2003. PMID: 12625839 Free PMC article.
-
Dementia with Lewy bodies.Dialogues Clin Neurosci. 2004 Sep;6(3):333-41. doi: 10.31887/DCNS.2004.6.3/imckeith. Dialogues Clin Neurosci. 2004. PMID: 22033743 Free PMC article.
-
Dementia with Lewy bodies - from scientific knowledge to clinical insights.Nat Rev Neurol. 2019 Feb;15(2):103-112. doi: 10.1038/s41582-018-0107-7. Nat Rev Neurol. 2019. PMID: 30559465 Review.
-
99mTc-M-TRODAT is not superior to (99m)Tc-TRODAT-1 for the diagnosis of Parkinson's disease.Eur J Nucl Med Mol Imaging. 2003 May;30(5):796-7. doi: 10.1007/s00259-003-1125-1. Epub 2003 Mar 5. Eur J Nucl Med Mol Imaging. 2003. PMID: 12618905 Clinical Trial. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
